Posted by Michael Wonder on 05 Aug 2015

Agenda for 1 October 2014 Transparency Commission meeting

Transparency Commission

The agenda for the 1 October 2014 Transparency Commission is now available. The Commission will consider the following new medicines and new uses for existing medicines:

  • Ustekinumab (Stelara) - new indication
  • Monovalent human rotavirus vaccine (Rotarix) - new vaccine
  • Pentavalent human bovine rotavirus vaccine (RotaTeq) - new vaccine
Michael Wonder

Posted by:

Michael Wonder

Posted in: